Sign in
Active, not recruitingPhase 1

Study of a birth control pill taken with ganfeborole, a tuberculosis medicine

Tests how ganfeborole affects birth control pill levels in women who cannot become pregnant.

Key facts

Who runs it
Glaxosmithkline Research & Development Limited
Where
Madrid, SpainSee the site
Registry title
A study to investigate the repeat-dose pharmacokinetics of a combined oral contraceptive when given alone and in combination with ganfeborole in female participants of non-childbearing potential.
Status
Active, not recruiting
Phase
Phase 1
People taking part
28 people, planned
Started
20 Aug 2026
Expected to end
31 Dec 2026
Type of study
Interventional
Record updated
7 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult women who cannot become pregnant. It studies how a birth control pill behaves in the body alone and together with ganfeborole.

Age
18 years or older
Sex
Women only

Where in Spain

  • Hospital Universitario La PazMadrid, SpainNo longer taking part

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Study of a birth control pill taken with ganfeborole, a tuberculosis medicineGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
7 October 2026